Showing results (111-120 of 415) with videos related to

Sort By:
Pageof 42
Genome Biology|March 29, 2023
CRISPR screens identify gene targets at breast cancer risk lociNatasha K Tuano, Jonathan Beesley, Murray Manning, et al.
NPJ Breast Cancer|July 3, 2019
LobSig is a multigene predictor of outcome in invasive lobular carcinomaAmy E McCart Reed, Samir Lal, Jamie R Kutasovic, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
Scientific Reports|January 26, 2018
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancerBo Gao, Yi Lu, Annemieke J M Nieuweboer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 13, 2016
Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFabHongyan Li, Bingjian Feng, Alexander Miron, et al.
Cancer Research|February 21, 2006
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significanceGeorgia Chenevix-Trench, Sue Healey, Sunil Lakhani, et al.
Genome Biology|January 9, 2020
Chromatin interactome mapping at 139 independent breast cancer risk signalsJonathan Beesley, Haran Sivakumaran, Mahdi Moradi Marjaneh, et al.
The HUGO Journal|December 2, 2010
Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer developmentJianjun Liu, Kartiki Vasant Desai, Yuqing Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2016
Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility LociBrett M Reid, Jennifer B Permuth, Y Ann Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2006
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Antonis C Antoniou, Livia Kelemen, et al.
Pageof 42